CEACAM5 and colorectal carcinoma: The abilities of CEA mRNA to predict CRC liver metastasis or local recurrence were reported, the sensitivities were 30% and 9%, and the ability of CEA levels to predict COAD recurrence was also reported, the sensitivity was 58.54%.[44] Compared with CEA mRNA, the predictive ability of the Riskscore model is improved.